APA (7th ed.) Citation

Burris, H. A., Chan, A., Bardia, A., Thaddeus Beck, J., Sohn, J., Neven, P., . . . Yardley, D. A. (2021). Safety and impact of dose reductions on efficacy in the randomised MONALEESA-2, -3 and -7 trials in hormone receptor-positive, HER2-negative advanced breast cancer. British Journal of Cancer, 125(5), 679. https://doi.org/10.1038/s41416-021-01415-9

Chicago Style (17th ed.) Citation

Burris, Howard A., et al. "Safety and Impact of Dose Reductions on Efficacy in the Randomised MONALEESA-2, -3 and -7 Trials in Hormone Receptor-positive, HER2-negative Advanced Breast Cancer." British Journal of Cancer 125, no. 5 (2021): 679. https://doi.org/10.1038/s41416-021-01415-9.

MLA (9th ed.) Citation

Burris, Howard A., et al. "Safety and Impact of Dose Reductions on Efficacy in the Randomised MONALEESA-2, -3 and -7 Trials in Hormone Receptor-positive, HER2-negative Advanced Breast Cancer." British Journal of Cancer, vol. 125, no. 5, 2021, p. 679, https://doi.org/10.1038/s41416-021-01415-9.